New recommendations to change the diagnostic criteria for Alzheimer's disease and recent advances in biomarker development may allow earlier diagnosis of this disease, potentially providing key tools for drug development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Opar, A. Hope builds for earlier detection of Alzheimer's disease. Nat Rev Drug Discov 9, 579–581 (2010). https://doi.org/10.1038/nrd3237
Issue Date:
DOI: https://doi.org/10.1038/nrd3237
This article is cited by
-
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases
Nature Reviews Drug Discovery (2011)
-
Alzheimer's failure raises questions about disease-modifying strategies
Nature Reviews Drug Discovery (2010)